Xie Jian 4
4 · Fulgent Genetics, Inc. · Filed Jul 28, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) President Xie Jian Sells 4,361 Shares
What Happened
- Xie Jian, President and Chief Operating Officer of Fulgent Genetics (FLGT), had 4,361 shares disposed on July 26, 2026. The shares were withheld at a price of $19.67 per share, producing a value of $85,781. The transaction is reported as code F (shares withheld to satisfy tax withholding).
Key Details
- Transaction date and price: July 26, 2026 — 4,361 shares @ $19.67/share.
- Total value of shares withheld: $85,781.
- Filing date: July 28, 2026 (filed within the typical two-business-day Form 4 window — timely).
- Shares owned after the transaction: not specified in the provided filing summary.
- Footnotes:
- F1: Shares were withheld to satisfy tax withholding upon vesting of restricted stock units assumed in the November 7, 2022 merger agreement; those awards were originally reported on Form 4 filed November 9, 2022.
- F2: Some securities are held by The Hsieh Family Dynasty Trust; Mr. Xie serves on the trust's investment committee and disclaims beneficial interest except for any pecuniary interest.
Context
- This was a tax-withholding disposition (cashless withholding) tied to RSU vesting, a routine administrative transaction rather than an open-market sale that signals a change in insider sentiment. No options were exercised and no new purchases were reported.
Insider Transaction Report
Form 4
Xie Jian
President and COO
Transactions
- Tax Payment
Common Stock
[F1]2026-07-26$19.67/sh−4,361$85,781→ 363,244 total
Holdings
- 220,816(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
- [F2]Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Signature
/s/ Paul Kim as Attorney-in-Fact|2026-07-28